Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Egile Nagusiak: | S. Hatakeyama, T. Yoneyama, Y. Tobisawa, H. Yamamoto, A. Imai, Y. Hashimoto, C. Ohyama |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Elsevier
2020-07-01
|
Saila: | European Urology Open Science |
Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S2666168320336442 |
Antzeko izenburuak
-
N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
nork: Hirotake Kodama, et al.
Argitaratua: (2021-02-01) -
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
nork: Shingo Hatakeyama, et al.
Argitaratua: (2013-01-01) -
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
nork: Itsuto Hamano, et al.
Argitaratua: (2020-07-01) -
Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
nork: Takuma Narita, et al.
Argitaratua: (2017-04-01) -
Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
nork: H. Yamamoto, et al.
Argitaratua: (2020-07-01)